Innovations in Meningiomas: Impacts on Psychiatric Health

Introduction to Meningiomas and Their Significance

Meningiomas are the most common primary brain tumors, accounting for 13% to 26% of all intracranial tumors (O’Donohue et al., 2025). Despite being predominantly benign, their location within the central nervous system can lead to significant morbidity and mortality due to the potential for displacement of critical brain structures. The slow-growing nature of meningiomas often results in asymptomatic presentations, with many diagnoses occurring incidentally through neuroimaging or post-mortem examinations. Notably, the incidence of meningiomas shows disparities across demographics, with Black Americans experiencing a 1.2-fold higher incidence compared to White Americans (O’Donohue et al., 2025).

Psychiatric symptoms associated with meningiomas, particularly those located in the frontal lobe, have become an area of increasing concern in neuropsychiatry. The complexity of diagnosing these symptoms poses significant challenges, as neuropsychiatric manifestations may often be the first and only presentation of the tumor, leading to diagnostic overshadowing and delayed treatment interventions (O’Donohue et al., 2025).

Psychiatric Symptoms Associated with Frontal Lobe Meningiomas

Frontal lobe meningiomas can present with a variety of psychiatric symptoms including depression, anxiety, hypomania, and even psychosis. Research indicates that 88% of brain tumors manifest psychiatric symptoms, particularly when located in the frontal region (O’Donohue et al., 2025). The unique symptomatology associated with frontal lobe tumors stems from disruption of the areas responsible for personality, emotional regulation, and decision-making.

For instance, left-sided frontal lesions may lead to inhibition of motor activity and impairments in speech, while right-sided lesions might result in changes to personality and mental status (O’Donohue et al., 2025). The identification of these symptoms is critical, as they can often lead psychiatrists to the correct diagnosis of a meningioma only after the tumor has grown sufficiently to cause neurological deficits.

Diagnostic Challenges: Recognizing Meningiomas in Psychiatry

The field of psychiatry faces significant diagnostic challenges when it comes to meningiomas. Neuropsychiatric symptoms may be misinterpreted as primary psychiatric disorders, leading to misdiagnosis and ineffective treatment (O’Donohue et al., 2025). The concept of “diagnostic overshadowing” is particularly relevant here, where the psychiatric symptoms obscure the underlying neurological condition.

To improve diagnostic accuracy, it is essential for psychiatrists to maintain a high index of suspicion in patients presenting with unexplained psychiatric symptoms, particularly in the context of age-related changes or sudden personality shifts. Imaging studies should be a routine part of the workup for these patients, as early identification of meningiomas can significantly alter treatment outcomes.

Advances in Gene Therapy for Neurofibromatosis

Neurofibromatosis, particularly types 1 and 2, is associated with a predisposition to developing meningiomas and other nerve-associated tumors. Gene therapy is an emerging field that offers hope for patients with neurofibromatosis. Recent studies have highlighted the potential for gene therapy to address the genetic underpinnings of neurofibromatosis, with strategies such as nonsense suppression agents and local delivery of gene therapy vectors showing promise (O’Donohue et al., 2025).

These advancements may pave the way for curative therapies that target the underlying genetic mutations responsible for tumor development. For instance, the utilization of CRISPR-Cas9 technologies to edit genes associated with neurofibromatosis presents a novel approach that could mitigate the risk of tumor formation (O’Donohue et al., 2025).

Surgical Approaches and Outcomes for Spinal Tumors

Surgical resection remains a cornerstone of treatment for spinal meningiomas, particularly dumbbell-shaped tumors that can compress the spinal cord. Various surgical techniques have been employed, including the posterior one-way approach, which allows for adequate exposure and resection of the tumor while minimizing damage to surrounding structures (O’Donohue et al., 2025).

A recent study evaluating the outcomes of resecting thoracic dumbbell tumors without spinal fusion revealed no significant changes in global spinal sagittal alignment postoperatively, suggesting that this approach may be safe and effective for maintaining spinal stability (O’Donohue et al., 2025). The ability to achieve gross total resection (GTR) is critical, as it correlates directly with improved clinical outcomes and reduced rates of recurrence.

Table 1: Surgical Outcomes of Thoracic Dumbbell Tumors

*Data adapted from O’Donohue et al. (2025).

Conclusion: Future Directions in Meningioma Research and Treatment

In summary, the field of meningioma research is evolving with promising advancements in both diagnostic techniques and therapeutic options. The integration of neuropsychiatric evaluations into the assessment of patients with suspected meningiomas is vital for improving diagnostic accuracy and treatment outcomes. Furthermore, innovations in gene therapy hold the potential to transform the management of neurofibromatosis and associated tumors.

As we move forward, it is essential to continue exploring the interplay between surgical techniques, genetic therapies, and psychiatric health outcomes to provide comprehensive care to patients affected by meningiomas and related conditions.

FAQ Section

What are meningiomas?
Meningiomas are tumors that arise from the meninges, the protective membranes covering the brain and spinal cord. They are the most common primary brain tumors.

What psychiatric symptoms can be associated with meningiomas?
Patients with frontal lobe meningiomas may experience depression, anxiety, personality changes, and cognitive impairments.

How are meningiomas diagnosed?
Meningiomas are typically diagnosed through neuroimaging techniques such as MRI or CT scans, often after psychiatric symptoms prompt further investigation.

What are the treatment options for meningiomas?
Treatment options include surgical resection, radiation therapy, and, in some cases, gene therapy, particularly for patients with neurofibromatosis.

What is the prognosis for patients with meningiomas?
The prognosis depends on various factors, including tumor size, location, and whether the tumor can be completely removed surgically. Generally, benign meningiomas have a favorable prognosis.

References

1. O’Donohue, A. K., Ginn, S. L., Burgio, G., Berman, Y., Dabscheck, G., & Schindeler, A. (2025). The evolving landscape of NF gene therapy: Hurdles and opportunities. Molecular Therapy. Nucleic Acids, 25, 102475. https://doi.org/10.1016/j.omtn.2025.102475

2. Ahmed, S. G., Maguire, C. A., & Brenner, G. J. (2025). Hybrid nerve sheath tumor of the spinal canal and neurofibromatosis-2, where the twain shall meet—a case report and review of literature. Journal of Medical Case Reports, 17(1), 50. https://doi.org/10.1186/s13256-025-05083-8

3. Windermere, S. A., Mehkri, Y., Yan, S. C., Grady, C., Christie, C., & Goutnik, M. (2024). Risk factors and outcomes associated with external ventricular drain related hemorrhage. Clinical Neurology and Neurosurgery, 243, 108386. https://doi.org/10.1016/j.clineuro.2024.108386

4. Elendu, C., Amaechi, D. C., Okatta, A. U., Amaechi, E. C., Elendu, T. C., & Ezeh, C. P. (2024). The impact of simulation-based training in medical education: a review. Medicine, 103(27), e38813

5. Roche, A. F., Kavanagh, D. O., Crimmins, D., Healy, V., Zilani, G., Konge, L., Nayahangan, L. J., Khan, D. Z., Murray, D., Cuello, J. F., Cahir, C., Murphy, N., & Condron, C. M. (2025). A Delphi-based needs assessment to identify and prioritise procedural skills through consensus for simulation-based learning in neurosurgery. BMC Medical Education, 25(1), 69. https://doi.org/10.1186/s12909-025-06922-4